NCT00792753View on ClinicalTrials.gov

"Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study EXCELLA II STUDY"

NACompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 30, 2011

Study Completion Date

March 8, 2014

Conditions
Coronary Artery Disease
Interventions
DEVICE

Medtronic Endeavor Coronary Stent System

coronary stent implantation

DEVICE

DESyne BD Novolimus Stent System

coronary stent implantation

DEVICE

DESyne Novolimus Stent System

coronary stent implantation

Trial Locations (8)

1023

Auckland City Hospital, Auckland

3010

University Hospital Bern, Bern

3015

Thoraxcentrum, Rotterdam

3168

Monash Medical Center, Melbourne

9000

University Hospital Gent, Ghent

22527

Universitäres Herz- und Gefäßzentrum, Hamburg

0401210

Instituto Dante Pazzanese, São Paulo

31-501

Jagiellonian University, Krakow

Sponsors
All Listed Sponsors
lead

Elixir Medical Corporation

INDUSTRY

NCT00792753 - "Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study EXCELLA II STUDY" | Biotech Hunter | Biotech Hunter